Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 4/2011

01.08.2011

An Update on Psychogenic Movement Disorders

verfasst von: Aviva Ellenstein, Sarah M. Kranick, Mark Hallett

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Psychogenic movement disorders (PMD) and other conversion disorders (CD) with apparent neurologic signs (neurologic CD) plague patients and perplex physicians. Due to a lack of objective evidence of underlying brain lesions, CD were largely abandoned by neurologists and remained poorly understood psychiatric diagnoses throughout most of the 20th century. Modern neuroscience now supports increasingly comprehensive biological models for these complex disorders, definitively establishing their place in both neurology and psychiatry. Although it is often clinically useful to distinguish a movement disorder as either “organic” or “psychogenic,” this dichotomy is difficult to defend scientifically. Here we describe the neuroimaging and neurophysiologic evidence for dysfunctional neural networks in PMD, explain the diagnostic potential of clinical neurophysiologic testing, discuss the promising if increasingly complex role of neuropsychiatric genetics, and review current treatment strategies.
Literatur
1.
Zurück zum Zitat Hallett M, Fahn S, Jankovic J, et al. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia: Lippincott Williams & Wilkins; 2006. Hallett M, Fahn S, Jankovic J, et al. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia: Lippincott Williams & Wilkins; 2006.
2.
Zurück zum Zitat Bogousslavsky J. Hysteria after Charcot: back to the future. Front Neurol Neurosci. 2011;29:137–61.PubMedCrossRef Bogousslavsky J. Hysteria after Charcot: back to the future. Front Neurol Neurosci. 2011;29:137–61.PubMedCrossRef
3.
Zurück zum Zitat Hallett M. Psychogenic movement disorders: a crisis for neurology. Curr Neurol Neurosci Rep. 2006;6:269–71.PubMedCrossRef Hallett M. Psychogenic movement disorders: a crisis for neurology. Curr Neurol Neurosci Rep. 2006;6:269–71.PubMedCrossRef
4.
Zurück zum Zitat Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009;47:1015–25.PubMedCrossRef Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009;47:1015–25.PubMedCrossRef
5.
Zurück zum Zitat Stone J, Wojcik W, Durrance D, et al. What should we say to patients with symptoms unexplained by disease? The “number needed to offend”. BMJ. 2002;325:1449–50.PubMedCrossRef Stone J, Wojcik W, Durrance D, et al. What should we say to patients with symptoms unexplained by disease? The “number needed to offend”. BMJ. 2002;325:1449–50.PubMedCrossRef
6.
Zurück zum Zitat Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol. 1988;50:431–55.PubMed Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol. 1988;50:431–55.PubMed
7.
Zurück zum Zitat Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol. 1995;65:231–57.PubMed Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol. 1995;65:231–57.PubMed
8.
Zurück zum Zitat American Psychiatric Association, American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington: American Psychiatric Association; 2000. American Psychiatric Association, American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington: American Psychiatric Association; 2000.
9.
Zurück zum Zitat Kranick SM, Ellenstein A, Hallett M. Psychiatric comorbidities and risk factors in psychogenic movement disorders: a biopsychosocial approach. European Neurological Journal. 2010;2:1–7. Kranick SM, Ellenstein A, Hallett M. Psychiatric comorbidities and risk factors in psychogenic movement disorders: a biopsychosocial approach. European Neurological Journal. 2010;2:1–7.
10.
Zurück zum Zitat Krem MM. Motor conversion disorders reviewed from a neuropsychiatric perspective. J Clin Psychiatry. 2004;65:783–90.PubMedCrossRef Krem MM. Motor conversion disorders reviewed from a neuropsychiatric perspective. J Clin Psychiatry. 2004;65:783–90.PubMedCrossRef
11.
Zurück zum Zitat Scott RL, Anson JG. Neural correlates of motor conversion disorder. Mot Control. 2009;13:161–84. Scott RL, Anson JG. Neural correlates of motor conversion disorder. Mot Control. 2009;13:161–84.
12.
Zurück zum Zitat • Vuilleumier P. The Neurophysiology of Self-Awareness Disorders in Conversion Hysteria. In The Neurology of Consciousness Cognitive Neuroscience and Neuropathology. Edited by Laureys S and Tononi G. Academic Press; 2009:282–302. This chapter cogently discusses the neuroimaging and neurophysiologic studies of conversion hysteria in the context a developing neurobiological model that includes disrupted mechanisms of self-awareness. • Vuilleumier P. The Neurophysiology of Self-Awareness Disorders in Conversion Hysteria. In The Neurology of Consciousness Cognitive Neuroscience and Neuropathology. Edited by Laureys S and Tononi G. Academic Press; 2009:282–302. This chapter cogently discusses the neuroimaging and neurophysiologic studies of conversion hysteria in the context a developing neurobiological model that includes disrupted mechanisms of self-awareness.
13.
Zurück zum Zitat Stone J, Carson A. Movement disorders: psychogenic movement disorders: what do neurologists do? Nat Rev Neurol. 2009;5:415–6.PubMedCrossRef Stone J, Carson A. Movement disorders: psychogenic movement disorders: what do neurologists do? Nat Rev Neurol. 2009;5:415–6.PubMedCrossRef
14.
Zurück zum Zitat LaFrance Jr WC, Miller IW, Ryan CE, et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009;14:591–6.PubMedCrossRef LaFrance Jr WC, Miller IW, Ryan CE, et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009;14:591–6.PubMedCrossRef
15.
Zurück zum Zitat Stone J, LaFrance WC, Jr., Levenson JL, et al. Issues for DSM-5: Conversion disorder. Am J Psychiatry, 167:626–627. Stone J, LaFrance WC, Jr., Levenson JL, et al. Issues for DSM-5: Conversion disorder. Am J Psychiatry, 167:626–627.
16.
Zurück zum Zitat Mayou R, Kirmayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry. 2005;162:847–55.PubMedCrossRef Mayou R, Kirmayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry. 2005;162:847–55.PubMedCrossRef
17.
Zurück zum Zitat Lowe B, Mundt C, Herzog W, et al. Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. Psychopathology. 2008;41:4–9.PubMedCrossRef Lowe B, Mundt C, Herzog W, et al. Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. Psychopathology. 2008;41:4–9.PubMedCrossRef
18.
Zurück zum Zitat Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology. 2010;74:223–8.PubMedCrossRef Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology. 2010;74:223–8.PubMedCrossRef
19.
Zurück zum Zitat Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133:1526–36.PubMedCrossRef Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133:1526–36.PubMedCrossRef
20.
21.
Zurück zum Zitat Vuilleumier P, Chicherio C, Assal F, et al. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain. 2001;124:1077–90.PubMedCrossRef Vuilleumier P, Chicherio C, Assal F, et al. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain. 2001;124:1077–90.PubMedCrossRef
22.
Zurück zum Zitat de Lange FP, Roelofs K, Toni I. Increased self-monitoring during imagined movements in conversion paralysis. Neuropsychologia. 2007;45:2051–8.PubMedCrossRef de Lange FP, Roelofs K, Toni I. Increased self-monitoring during imagined movements in conversion paralysis. Neuropsychologia. 2007;45:2051–8.PubMedCrossRef
23.
Zurück zum Zitat Cojan Y, Waber L, Carruzzo A, et al. Motor inhibition in hysterical conversion paralysis. Neuroimage. 2009;47:1026–37.PubMedCrossRef Cojan Y, Waber L, Carruzzo A, et al. Motor inhibition in hysterical conversion paralysis. Neuroimage. 2009;47:1026–37.PubMedCrossRef
24.
Zurück zum Zitat de Lange FP, Toni I, Roelofs K. Altered connectivity between prefrontal and sensorimotor cortex in conversion paralysis. Neuropsychologia. 2010;48:1782–8.PubMedCrossRef de Lange FP, Toni I, Roelofs K. Altered connectivity between prefrontal and sensorimotor cortex in conversion paralysis. Neuropsychologia. 2010;48:1782–8.PubMedCrossRef
25.
Zurück zum Zitat Stone J, Vuilleumier P, Friedman JH. Conversion disorder: separating “how” from “why”. Neurology. 2010;74:190–1.PubMedCrossRef Stone J, Vuilleumier P, Friedman JH. Conversion disorder: separating “how” from “why”. Neurology. 2010;74:190–1.PubMedCrossRef
26.
Zurück zum Zitat Gaig C, Marti MJ, Tolosa E, et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov Disord. 2006;21:1994–8.PubMedCrossRef Gaig C, Marti MJ, Tolosa E, et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov Disord. 2006;21:1994–8.PubMedCrossRef
28.
Zurück zum Zitat Liepert J, Hassa T, Tuscher O, et al. Motor excitability during movement imagination and movement observation in psychogenic lower limb paresis. J Psychosom Res. 2010;70:59–65.PubMedCrossRef Liepert J, Hassa T, Tuscher O, et al. Motor excitability during movement imagination and movement observation in psychogenic lower limb paresis. J Psychosom Res. 2010;70:59–65.PubMedCrossRef
29.
Zurück zum Zitat Desmurget M, Sirigu A. A parietal-premotor network for movement intention and motor awareness. Trends Cogn Sci. 2009;13:411–9.PubMedCrossRef Desmurget M, Sirigu A. A parietal-premotor network for movement intention and motor awareness. Trends Cogn Sci. 2009;13:411–9.PubMedCrossRef
30.
Zurück zum Zitat Schwingenschuh P, Katschnig P, Edwards MJ, et al. The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurology. 2011;76:610–4.PubMedCrossRef Schwingenschuh P, Katschnig P, Edwards MJ, et al. The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurology. 2011;76:610–4.PubMedCrossRef
31.
Zurück zum Zitat Hariri AR. The neurobiology of individual differences in complex behavioral traits. Annu Rev Neurosci. 2009;32:225–47.PubMedCrossRef Hariri AR. The neurobiology of individual differences in complex behavioral traits. Annu Rev Neurosci. 2009;32:225–47.PubMedCrossRef
32.
Zurück zum Zitat • Caspi A, Hariri AR, Holmes A, et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167:509–527. Following from a detailed review of the serotonin transporter gene and stress sensitivity, the authors discuss approaches to the challenging field of gene-environment research. PubMedCrossRef • Caspi A, Hariri AR, Holmes A, et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167:509–527. Following from a detailed review of the serotonin transporter gene and stress sensitivity, the authors discuss approaches to the challenging field of gene-environment research. PubMedCrossRef
33.
Zurück zum Zitat Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci. 2006;7:583–90.PubMedCrossRef Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci. 2006;7:583–90.PubMedCrossRef
34.
Zurück zum Zitat Hallett M, Lang AE, Jankovic J, et al. Psychogenic movement disorders & other conversion disorders. Cambridge: Cambridge University Press; 2011. Hallett M, Lang AE, Jankovic J, et al. Psychogenic movement disorders & other conversion disorders. Cambridge: Cambridge University Press; 2011.
35.
Zurück zum Zitat Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 2009;10:446–57.PubMedCrossRef Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 2009;10:446–57.PubMedCrossRef
36.
Zurück zum Zitat • Lupien SJ, McEwen BS, Gunnar MR, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009,10:434–445. The authors synthesize the animal and human research on the age-dependent pathophysiology of stress. PubMedCrossRef • Lupien SJ, McEwen BS, Gunnar MR, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009,10:434–445. The authors synthesize the animal and human research on the age-dependent pathophysiology of stress. PubMedCrossRef
37.
Zurück zum Zitat Feinstein A, Stergiopoulos V, Fine J, et al. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:169–76.PubMed Feinstein A, Stergiopoulos V, Fine J, et al. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:169–76.PubMed
38.
Zurück zum Zitat Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry. 2005;66:1529–34.PubMedCrossRef Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry. 2005;66:1529–34.PubMedCrossRef
39.
Zurück zum Zitat Binder EB, Owens MJ, Liu W, et al. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry. 2010;67:369–79.PubMedCrossRef Binder EB, Owens MJ, Liu W, et al. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry. 2010;67:369–79.PubMedCrossRef
40.
Zurück zum Zitat Zhou Z, Zhu G, Hariri AR, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature. 2008;452:997–1001.PubMedCrossRef Zhou Z, Zhu G, Hariri AR, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature. 2008;452:997–1001.PubMedCrossRef
41.
Zurück zum Zitat • Stone J. The bare essentials: Functional symptoms in neurology. Pract Neurol 2009, 9:179–189. This article presents important, practical advice for the neurologist’s approach to patients with CD. PubMedCrossRef • Stone J. The bare essentials: Functional symptoms in neurology. Pract Neurol 2009, 9:179–189. This article presents important, practical advice for the neurologist’s approach to patients with CD. PubMedCrossRef
42.
Zurück zum Zitat Hinson VK, Weinstein S, Bernard B, et al. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006;12:177–80.PubMedCrossRef Hinson VK, Weinstein S, Bernard B, et al. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006;12:177–80.PubMedCrossRef
43.
Zurück zum Zitat Speckens AE, van Hemert AM, Spinhoven P, et al. Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ. 1995;311:1328–32.PubMed Speckens AE, van Hemert AM, Spinhoven P, et al. Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ. 1995;311:1328–32.PubMed
44.
Zurück zum Zitat LaFrance Jr WC. Friedman JH. cognitive behavioral therapy for psychogenic movement disorder. Mov Disord. 2009;24:1856–7.PubMedCrossRef LaFrance Jr WC. Friedman JH. cognitive behavioral therapy for psychogenic movement disorder. Mov Disord. 2009;24:1856–7.PubMedCrossRef
45.
Zurück zum Zitat Baslet G, Hill J. Case report: brief mindfulness-based psychotherapeutic intervention during inpatient hospitalization in a patient with conversion and dissociation. Clinical Case Studies 2011. doi: 10.1177/1534650110396359. Baslet G, Hill J. Case report: brief mindfulness-based psychotherapeutic intervention during inpatient hospitalization in a patient with conversion and dissociation. Clinical Case Studies 2011. doi: 10.​1177/​1534650110396359​.
46.
Zurück zum Zitat Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74:1986–94.PubMedCrossRef Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74:1986–94.PubMedCrossRef
47.
Zurück zum Zitat Dallocchio C, Arbasino C, Klersy C, et al. The effects of physical activity on psychogenic movement disorders. Mov Disord. 2010;25:421–5.PubMedCrossRef Dallocchio C, Arbasino C, Klersy C, et al. The effects of physical activity on psychogenic movement disorders. Mov Disord. 2010;25:421–5.PubMedCrossRef
48.
Zurück zum Zitat Van Nuenen BF, Wohlgemuth M, Wong Chung RE, et al. Acupuncture for psychogenic movement disorders: treatment or diagnostic tool? Mov Disord. 2007;22:1353–5.PubMedCrossRef Van Nuenen BF, Wohlgemuth M, Wong Chung RE, et al. Acupuncture for psychogenic movement disorders: treatment or diagnostic tool? Mov Disord. 2007;22:1353–5.PubMedCrossRef
49.
Zurück zum Zitat Moene FC, Spinhoven P, Hoogduin KA, et al. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn. 2003;51:29–50.PubMedCrossRef Moene FC, Spinhoven P, Hoogduin KA, et al. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn. 2003;51:29–50.PubMedCrossRef
50.
Zurück zum Zitat Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord. 2010;25:1501–4.PubMedCrossRef Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord. 2010;25:1501–4.PubMedCrossRef
Metadaten
Titel
An Update on Psychogenic Movement Disorders
verfasst von
Aviva Ellenstein
Sarah M. Kranick
Mark Hallett
Publikationsdatum
01.08.2011
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 4/2011
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-011-0205-z

Weitere Artikel der Ausgabe 4/2011

Current Neurology and Neuroscience Reports 4/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.